PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. [electronic resource]
Producer: 20101004Description: 4356-67 p. digitalISSN:- 1945-7170
- Animals
- Aorta -- drug effects
- Apolipoproteins E -- genetics
- Benzamides
- Biglycan
- Cells, Cultured
- Dietary Fats -- administration & dosage
- Extracellular Matrix Proteins -- metabolism
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Glycosaminoglycans -- metabolism
- Humans
- Imatinib Mesylate
- Lipids -- analysis
- Lipoproteins, LDL -- metabolism
- Male
- Mice
- Mice, Knockout
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Muscle, Smooth, Vascular -- cytology
- Phosphorylation -- drug effects
- Piperazines -- pharmacology
- Platelet-Derived Growth Factor -- pharmacology
- Protein Binding -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proteoglycans -- metabolism
- Pyrimidines -- pharmacology
- RNA Interference
- Receptor, Platelet-Derived Growth Factor beta -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.